[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
[ Tue, May 09th 2023 ]: WOPRAI
Yatin Suneja Maintained (BTAI) at Strong Buy with Decreased Target to $46 on, May 9th, 2023
Yatin Suneja of Guggenheim, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $50 to $46 on, May 9th, 2023.
Yatin has made no other calls on BTAI in the last 4 months.
There are 4 other peers that have a rating on BTAI. Out of the 4 peers that are also analyzing BTAI, 2 agree with Yatin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $22 on, Friday, March 10th, 2023
- Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Increased Target to $26 on, Thursday, January 26th, 2023
These are the ratings of the 2 analyists that currently disagree with Yatin
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $66 on, Tuesday, March 21st, 2023
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $38 on, Wednesday, February 8th, 2023